About this trial
The aim of this study is to compare AMG and EMG (Philips IntelliVue NMT module and Senzime TetraGraph) in the objective monitoring of neuromuscular blocking in children between the age of 6 months and 2 years.The monitoring will be done bilaterally either on n.ulnaris or n. tibialis. The hypothesis of the study is that AMG will indicate faster recovery time (time to return to TOF 90%) from neuromuscular block than EMG.
Eligibility criteria
Qualifiers
Patients 6 months - 2 years of age
Scheduled for elective surgery under general anaesthesia with intubation and use of rocuronium
American Society of Anesthesiologists (ASA) physical status classification I to III
Disqualifiers
Known allergy to rocuronium
Neuromuscular disease that may interfere with neuromuscular data
Indication for rapid sequence induction
Prone position
Trial design
Treatments tested in this trial
- Acceleromyography (AMG)
- Electromyography (EMG)
Treatment groups
Sponsors and collaborators
Matias Vested
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution